Amarantus Bioscience Holdings Inc (AMBS)

[joboggi]

I am sorry, but this pr does not meet scientific standards. Nothing is advanced by the Onemedforum release. There was NO statistical significance. Even Gerald's dad said the study needed to be repeated.

A recent email from Gerald agreed with that, and Gerald really is out of his depth. He needs a pr person and an in house attorney to help him guide his releases. ( I posted the email )

Since the number of rodents in the study was too low, they WILL get to do this again, but to say this will enable human trials, is terribly misleading on the part of AMBS, and is reason for shareholder complaints.